Medications By Class	Target Behaviors	Adverse Effects	Monitoring
Typical Antipsychotics (e.g haloperidol, chlorpromazine)	Agitation, aggression, hyperactivity, self-injury	Extrapyramidal symptoms, tardive dyskinesia	AIMS
Atypical Antipsychotics (e.g risperidone, aripiprazole, olanzapine)	Irritability, aggressiveness, hyperactivity, self- injurious behavior, repetitive behaviors	Weight gain, somnolence, increased risk of diabetes, extrapyramidal symptoms, akathisia, tardive dyskinesia	Blood glucose, HbA1C, lipids AIMS
Mood Stabilizers (e.g., lithium, valproic acid, carbamazepine)	Mood lability, aggression, impulsivity, self-injurious behavior	Lithium: tremor, renal and thyroid toxicity, Valproate: tremor, sedation, weight gain Carbamazepine: nausea, vomiting	Renal and thyroid monitoring for lithium, liver function tests, CBC, and ammonia with valproic acid, regular drug levels for all three
SSRIs (e.g fluoxetine, sertraline, fluvoxamine)	Depressed mood, anxiety, self-injurious behavior, repetitive behaviors	Activation, agitation, aggression, nausea	None specific
Stimulants (e.g methylphenidate)	Hyperactivity, inattention, impulsivity	Loss of appetite, insomnia, depressed mood	Height, weight, vital signs
Alpha-agonists (e.g. clonidine, guanfacine)	Hyperactivity, inattention, impulsivity, tics	Hypotension, sedation, increased depression	Vital signs